Clinical Trials
4 trialsNCT05557240 2022-10-12
Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients
Shanghai 10th People's Hospital
Phase NA Unknown
NCT05281926 2022-03-16
A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients
National Taiwan University Hospital
Phase 1 Unknown
NCT00553683 2014-01-14
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Phase 1/2 Unknown
NCT00493545 2008-05-07
Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
Nventa Biopharmaceuticals Corporation
Phase 1 Unknown